{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Lupron", "query": { "condition": "Lupron" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 96, "total_pages": 10, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Lupron&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-05-22T05:34:17.446Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03695237", "title": "A Study to Evaluate Leuprolide Acetate 45 mg 6-Month Formulation in Children With Central Precocious Puberty (CPP)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Central Precocious Puberty (CPP)" ], "interventions": [ { "name": "Leuprolide Acetate (LA)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "2 Years to 11 Years" }, "enrollment_count": 45, "start_date": "2018-10-24", "completion_date": "2023-11-29", "has_results": true, "last_update_posted_date": "2024-05-29", "last_synced_at": "2026-05-22T05:34:17.446Z", "location_count": 17, "location_summary": "Long Beach, California • San Diego, California • Aurora, Colorado + 14 more", "locations": [ { "city": "Long Beach", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Greenwood Village", "state": "Colorado" }, { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03695237" }, { "nct_id": "NCT02663908", "title": "A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Prostate Cancer" ], "interventions": [ { "name": "Degarelix", "type": "DRUG" }, { "name": "Leuprolide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ferring Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "MALE", "summary": "Male only" }, "enrollment_count": 545, "start_date": "2016-04-19", "completion_date": "2021-03-29", "has_results": true, "last_update_posted_date": "2022-06-29", "last_synced_at": "2026-05-22T05:34:17.446Z", "location_count": 48, "location_summary": "Birmingham, Alabama • Tucson, Arizona • Little Rock, Arkansas + 42 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02663908" }, { "nct_id": "NCT00667446", "title": "Safety Extension Study Of Leuprolide Acetate (Lupron Depot) In The Treatment Of Central Precocious Puberty", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Precocious", "Leuprolide Acetate", "Luteinizing Hormone (LH)", "Gonadotrophin-releasing Hormone Agonist (GnRHa)", "Tanner Staging", "Depot Formulation", "Suppression of LH", "Central Precocious Puberty (CPP)", "Gonadotrophin-releasing Hormone (GnRH)", "Lupron", "GnRH Analog", "Pediatrics Central Precocious Puberty" ], "interventions": [ { "name": "Leuprolide Acetate 3 Month Depot", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie (prior sponsor, Abbott)", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 72, "start_date": "2008-12", "completion_date": "2013-01", "has_results": true, "last_update_posted_date": "2014-01-09", "last_synced_at": "2026-05-22T05:34:17.446Z", "location_count": 16, "location_summary": "Birmingham, Alabama • Long Beach, California • Los Angeles, California + 13 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Greenwood Village", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00667446" }, { "nct_id": "NCT02712320", "title": "Open-Label Safety Extension Study in Patients Who Have Previously Participated and Have Benefited From LMIS 50 mg", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Prostatic Neoplasms" ], "interventions": [ { "name": "LMIS 50 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Foresee Pharmaceuticals Co., Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 30, "start_date": "2016-02", "completion_date": "2017-12-19", "has_results": true, "last_update_posted_date": "2019-03-26", "last_synced_at": "2026-05-22T05:34:17.446Z", "location_count": 7, "location_summary": "Homewood, Alabama • San Diego, California • Meridian, Idaho + 4 more", "locations": [ { "city": "Homewood", "state": "Alabama" }, { "city": "San Diego", "state": "California" }, { "city": "Meridian", "state": "Idaho" }, { "city": "Lawrenceville", "state": "New Jersey" }, { "city": "Concord", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02712320" }, { "nct_id": "NCT00630799", "title": "Efficacy and Safety Study of a New Leuprolide Acetate 17 mg Depot to Treat Prostate Cancer Patients", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Prostate Cancer" ], "interventions": [ { "name": "leuprolide acetate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GP-Pharm", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 20, "start_date": "2008-05", "completion_date": "2009-07", "has_results": false, "last_update_posted_date": "2010-09-09", "last_synced_at": "2026-05-22T05:34:17.446Z", "location_count": 8, "location_summary": "New Port Richey, Florida • Lawrenceville, New Jersey • Poughkeepsie, New York + 5 more", "locations": [ { "city": "New Port Richey", "state": "Florida" }, { "city": "Lawrenceville", "state": "New Jersey" }, { "city": "Poughkeepsie", "state": "New York" }, { "city": "Winston-Salem", "state": "North Carolina" }, { "city": "Bryn Mawr", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00630799" }, { "nct_id": "NCT00388804", "title": "External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Prostate Cancer" ], "interventions": [ { "name": "Radiation Therapy", "type": "PROCEDURE" }, { "name": "Bicalutamide", "type": "DRUG" }, { "name": "Leuprolide", "type": "DRUG" }, { "name": "Goserelin", "type": "DRUG" }, { "name": "Flutamide", "type": "DRUG" }, { "name": "Questionnaire", "type": "BEHAVIORAL" } ], "intervention_types": [ "PROCEDURE", "DRUG", "BEHAVIORAL" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "MALE", "summary": "Male only" }, "enrollment_count": 39, "start_date": "2005-02", "completion_date": "2011-04", "has_results": true, "last_update_posted_date": "2012-08-08", "last_synced_at": "2026-05-22T05:34:17.446Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00388804" }, { "nct_id": "NCT03009981", "title": "A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Prostate Cancer" ], "interventions": [ { "name": "Apalutamide", "type": "DRUG" }, { "name": "LHRH Analogue", "type": "DRUG" }, { "name": "Abiraterone Acetate", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alliance Foundation Trials, LLC.", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 504, "start_date": "2017-03-06", "completion_date": "2025-06-25", "has_results": false, "last_update_posted_date": "2025-12-18", "last_synced_at": "2026-05-22T05:34:17.446Z", "location_count": 69, "location_summary": "Phoenix, Arizona • Chula Vista, California • Duarte, California + 58 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Chula Vista", "state": "California" }, { "city": "Duarte", "state": "California" }, { "city": "Fremont", "state": "California" }, { "city": "Fresno", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03009981" }, { "nct_id": "NCT04666129", "title": "Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Metastatic Castration-Resistant Prostate Cancer", "Metastatic Castration-Sensitive Prostate Cancer", "Non-Metastatic Castration-Resistant Prostate Cancer" ], "interventions": [ { "name": "Relugolix", "type": "DRUG" }, { "name": "Abiraterone", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" }, { "name": "Methylprednisolone", "type": "DRUG" }, { "name": "Apalutamide", "type": "DRUG" }, { "name": "Docetaxel", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 48, "start_date": "2021-02-18", "completion_date": "2024-05-28", "has_results": false, "last_update_posted_date": "2025-08-17", "last_synced_at": "2026-05-22T05:34:17.446Z", "location_count": 16, "location_summary": "Tucson, Arizona • Little Rock, Arkansas • Lakewood, Colorado + 13 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Lakewood", "state": "Colorado" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Worcester", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04666129" }, { "nct_id": "NCT02452931", "title": "Study of Leuprolide Acetate Injectable Suspension in the Treatment of Central Precocious Puberty", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Precocious Puberty, Central" ], "interventions": [ { "name": "Leuprolide Acetate 45 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Tolmar Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "9 Years", "sex": "ALL", "summary": "2 Years to 9 Years" }, "enrollment_count": 64, "start_date": "2015-08-31", "completion_date": "2018-09-05", "has_results": true, "last_update_posted_date": "2020-06-02", "last_synced_at": "2026-05-22T05:34:17.446Z", "location_count": 10, "location_summary": "San Diego, California • Hollywood, Florida • Jacksonville, Florida + 7 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Hollywood", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT02452931" }, { "nct_id": "NCT00254397", "title": "Melanoma Vaccine With Peptides and Leuprolide", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Melanoma" ], "interventions": [ { "name": "Leuprolide", "type": "DRUG" }, { "name": "GP100: 209-217(210M) Peptide", "type": "BIOLOGICAL" }, { "name": "MAGE-3 Peptide", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 98, "start_date": "2005-11", "completion_date": "2012-10", "has_results": true, "last_update_posted_date": "2019-10-16", "last_synced_at": "2026-05-22T05:34:17.446Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00254397" } ] }